Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of edaravone + dexborneol injection in intracerebral hemorrhage
CTR20231571Phase 2Active
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edaravone dexborneol in intracerebral hemorrhage (ICH), sponsored by Simcere Pharmaceutical Group. Started Jul 2023; status: active.
02
Drugs
edaravone dexborneol
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on CTR20231571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231571.